Skip to content

A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-502348-11-00
Acronym
C5871001/SGNBB228100
Enrollment
45
Registered
2023-08-08
Start date
2023-12-15
Completion date
2025-03-17
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms, Cutaneous Melanoma, Mesothelioma, Non-small Cell Lung Cancer, Pancreatic Neoplasms

Interventions

None listed

Sponsors

Seagen Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Germany, Italy

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026